Literature DB >> 23567452

Outbreak of cutaneous leishmaniasis in Fuenlabrada, Madrid.

M Aguado1, P Espinosa, A Romero-Maté, J C Tardío, S Córdoba, J Borbujo.   

Abstract

BACKGROUND: Leishmaniasis, an endemic infection in Spain, is caused by protozoan parasites of the Leishmania genus. Between 2010 and 2012, there was an outbreak of cutaneous and visceral leishmaniasis in Fuenlabrada, Madrid.
OBJECTIVES: To describe the cases of cutaneous leishmaniasis diagnosed over a 17-month period at the dermatology department of Hospital de Fuenlabrada.
MATERIAL AND METHODS: We analyzed the epidemiological, clinical, histological, and microbiological features of each case and also evaluated the treatments administered and outcomes.
RESULTS: We studied 149 cases. The incidence of cutaneous leishmaniasis showed a peak in the age range between 46 and 60 years and was similar in men and women. At the time of consultation, the lesions had been present for between 2 and 6 months in the majority of patients. The most common clinical presentation was with erythematous plaques and papules without crusts (52% of cases). Lesions were most often located in sun-exposed areas and were multiple in 57% of patients. In 67% of cases, the histological study showed non-necrotizing granulomatous dermatitis with no evidence of parasites using conventional staining methods. Diagnosis was confirmed by polymerase chain reaction (PCR) in 98% of patients. In the remaining cases, the histological study revealed Leishman-Donovan bodies in the skin. Intralesional pentavalent antimonials were the most commonly used drugs (76% of cases) and produced satisfactory results.
CONCLUSIONS: We have presented a large series of cases of cutaneous leishmaniasis diagnosed in the context of an outbreak. Multiple papules were the most common clinical presentation, with histology that showed non-necrotizing granulomatous dermatitis with no evidence of parasites. PCR of skin samples was the test that most frequently provided the diagnosis.
Copyright © 2012 Elsevier España, S.L. and AEDV. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23567452     DOI: 10.1016/j.adengl.2013.03.005

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  10 in total

1.  Histopathological features of skin lesions in patients affected by non-ulcerated or atypical cutaneous leishmaniasis in Honduras, Central America.

Authors:  Carmen Maria Sandoval Pacheco; Gabriela Venicia Araujo Flores; Aurea Favero Ferreira; Wilfredo Sosa Ochoa; Vânia Lúcia Ribeiro da Matta; Concepción Zúniga Valeriano; Carlos Eduardo Pereira Corbett; Marcia Dalastra Laurenti
Journal:  Int J Exp Pathol       Date:  2018-11-27       Impact factor: 1.925

2.  Characterisation of the ex vivo virulence of Leishmania infantum isolates from Phlebotomus perniciosus from an outbreak of human leishmaniosis in Madrid, Spain.

Authors:  Gustavo Domínguez-Bernal; Maribel Jiménez; Ricardo Molina; Lara Ordóñez-Gutiérrez; Abel Martínez-Rodrigo; Alicia Mas; Maria Teresa Cutuli; Javier Carrión
Journal:  Parasit Vectors       Date:  2014-11-07       Impact factor: 3.876

3.  Resurgence of cutaneous leishmaniasis in Israel, 2001-2012.

Authors:  Dan Gandacu; Yael Glazer; Emilia Anis; Isabella Karakis; Bruce Warshavsky; Paul Slater; Itamar Grotto
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

4.  An itching plaque.

Authors:  Juan Garcias-Ladaria; Karel López-Brito; Marta Pascual-López; Vicenç Rocamora
Journal:  Dermatol Pract Concept       Date:  2015-01-31

5.  Caseating granulomas in cutaneous leishmaniasis.

Authors:  Jessica Aoun; Robert Habib; Khalil Charaffeddine; Suad Taraif; Asif Loya; Ibrahim Khalifeh
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

6.  Topical Amphotericin B Semisolid Dosage Form for Cutaneous Leishmaniasis: Physicochemical Characterization, Ex Vivo Skin Permeation and Biological Activity.

Authors:  Diana Berenguer; Mª Magdalena Alcover; Marcella Sessa; Lyda Halbaut; Carme Guillén; Antoni Boix-Montañés; Roser Fisa; Ana Cristina Calpena-Campmany; Cristina Riera; Lilian Sosa
Journal:  Pharmaceutics       Date:  2020-02-12       Impact factor: 6.321

7.  Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.

Authors:  Marta Garrido-Jareño; Antonio Sahuquillo-Torralba; Rabab Chouman-Arcas; Iván Castro-Hernández; José Miguel Molina-Moreno; Margarita Llavador-Ros; María Dolores Gómez-Ruiz; José Luis López-Hontangas; Rafael Botella-Estrada; Miguel Salavert-Lleti; Javier Pemán-García
Journal:  Parasit Vectors       Date:  2020-01-13       Impact factor: 3.876

8.  In situ cellular immune response in non-ulcerated skin lesions due to Leishmania (L.) infantum chagasi infection.

Authors:  Carmen Sandoval; Gabriela Araujo; Wilfredo Sosa; Sara Avalos; Fernando Silveira; Carlos Corbett; Concepción Zúniga; Marcia Laurenti
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-02-26

9.  Seropositivity rates for agents of canine vector-borne diseases in Spain: a multicentre study.

Authors:  Guadalupe Miró; Ana Montoya; Xavier Roura; Rosa Gálvez; Angel Sainz
Journal:  Parasit Vectors       Date:  2013-04-22       Impact factor: 3.876

10.  Multilocus sequence analysis for Leishmania braziliensis outbreak investigation.

Authors:  Mariel A Marlow; Mariana C Boité; Gabriel Eduardo M Ferreira; Mario Steindel; Elisa Cupolillo
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.